Elekta announced today that its Evo CT Linac received FDA 510(k) clearance, making it available to U.S. radiation oncology ...

Stockholm-based Elekta has begun clinical trials on its Unity machine, which combines a linear accelerator and high-field magnetic resonance imaging (MRI) to better define and track tumors during ...

ATLANTA, June 5 /PRNewswire/ -- Elekta, a world class leader in advanced radiation therapy and radiosurgery, has been selected to supply multiple Elekta Synergy(R) digital linear accelerator systems ...

In order to deliver Adaptive Radiation Therapy (ART) for cancer, Elekta, a global leader in precision radiation therapy, will launch an advanced AI-enabled CT-Linac (linear accelerator) by the name ...

New Delhi, Dec 1 (PTI) Precision radiation therapy major Elekta has introduced its latest CT-based linear accelerator, Evo, to the Indian market to provide high-definition AI-enhanced imaging ...

Elekta, a company based in Sweden, is one of the world's leaders in developing some of the most cutting-edge cancer treatment technologies — and Mary Bird Perkins Cancer Center has worked with them ...

Capital Markets Day presentations highlight opportunities and potential based on Elekta's strong position STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, ...

STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, ...